Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study

Abstract Background Guidelines for the management of diabetic ketoacidosis (DKA) do not consider the type of underlying diabetes. We aimed to compare the occurrence of metabolic adverse events and the recovery time for DKA according to diabetes type. Methods Multicentre retrospective study conducted...

Full description

Bibliographic Details
Main Authors: Adrien Balmier, Fadia Dib, Arnaud Serret-Larmande, Etienne De Montmollin, Victorine Pouyet, Benjamin Sztrymf, Bruno Megarbane, Abirami Thiagarajah, Didier Dreyfuss, Jean-Damien Ricard, Damien Roux
Format: Article
Language:English
Published: SpringerOpen 2019-08-01
Series:Annals of Intensive Care
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13613-019-0567-y
_version_ 1819195671566090240
author Adrien Balmier
Fadia Dib
Arnaud Serret-Larmande
Etienne De Montmollin
Victorine Pouyet
Benjamin Sztrymf
Bruno Megarbane
Abirami Thiagarajah
Didier Dreyfuss
Jean-Damien Ricard
Damien Roux
author_facet Adrien Balmier
Fadia Dib
Arnaud Serret-Larmande
Etienne De Montmollin
Victorine Pouyet
Benjamin Sztrymf
Bruno Megarbane
Abirami Thiagarajah
Didier Dreyfuss
Jean-Damien Ricard
Damien Roux
author_sort Adrien Balmier
collection DOAJ
description Abstract Background Guidelines for the management of diabetic ketoacidosis (DKA) do not consider the type of underlying diabetes. We aimed to compare the occurrence of metabolic adverse events and the recovery time for DKA according to diabetes type. Methods Multicentre retrospective study conducted at five adult intermediate and intensive care units in Paris and its suburbs, France. All patients admitted for DKA between 2013 and 2014 were included. Patients were grouped and compared according to the underlying type of diabetes into three groups: type 1 diabetes, type 2 or secondary diabetes, and DKA as the first presentation of diabetes. Outcomes of interest were the rate of metabolic complications (hypoglycaemia or hypokalaemia) and the recovery time. Results Of 122 patients, 60 (49.2%) had type 1 diabetes, 28 (22.9%) had type 2 or secondary diabetes and 34 (27.9%) presented with DKA as the first presentation of diabetes (newly diagnosed diabetes). Despite having received lower insulin doses, hypoglycaemia was more frequent in patients with type 1 diabetes (76.9%) than in patients with type 2 or secondary diabetes (50.0%) and in patients with newly diagnosed diabetes (54.6%) (p = 0.026). In contrast, hypokalaemia was more frequent in the latter group (82.4%) than in patients with type 1 diabetes (57.6%) and type 2 or secondary diabetes (51.9%) (p = 0.022). The median recovery times were not significantly different between groups. Conclusions Rates of metabolic complications associated with DKA treatment differ significantly according to underlying type of diabetes. Decreasing insulin dose may limit those complications. DKA treatment recommendations should take into account the type of diabetes.
first_indexed 2024-12-23T02:16:28Z
format Article
id doaj.art-8345b3c23e3243be8f54c32f87e3e1db
institution Directory Open Access Journal
issn 2110-5820
language English
last_indexed 2024-12-23T02:16:28Z
publishDate 2019-08-01
publisher SpringerOpen
record_format Article
series Annals of Intensive Care
spelling doaj.art-8345b3c23e3243be8f54c32f87e3e1db2022-12-21T18:03:39ZengSpringerOpenAnnals of Intensive Care2110-58202019-08-01911810.1186/s13613-019-0567-yInitial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective studyAdrien Balmier0Fadia Dib1Arnaud Serret-Larmande2Etienne De Montmollin3Victorine Pouyet4Benjamin Sztrymf5Bruno Megarbane6Abirami Thiagarajah7Didier Dreyfuss8Jean-Damien Ricard9Damien Roux10Intensive Care Unit, Louis Mourier Hospital, AP-HPINSERM, CIC 1417, F-CRIN, I-REIVACDepartment of Epidemiology, Biostatistics and Clinical Research, Bichat-Claude-Bernard Hospital, Université de Paris, AP-HPIntensive Care Unit, Centre Hospitalier de Saint-Denis, Hopital DelafontaineIntensive Care Unit, Hôpital René-DubosService de Réanimation polyvalente et surveillance continue, Université Paris Sud, Hôpital Antoine Béclère, AP-HPDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, AP-HP, Université de ParisIntensive Care Unit, Louis Mourier Hospital, AP-HPIntensive Care Unit, Louis Mourier Hospital, AP-HPIntensive Care Unit, Louis Mourier Hospital, AP-HPIntensive Care Unit, Louis Mourier Hospital, AP-HPAbstract Background Guidelines for the management of diabetic ketoacidosis (DKA) do not consider the type of underlying diabetes. We aimed to compare the occurrence of metabolic adverse events and the recovery time for DKA according to diabetes type. Methods Multicentre retrospective study conducted at five adult intermediate and intensive care units in Paris and its suburbs, France. All patients admitted for DKA between 2013 and 2014 were included. Patients were grouped and compared according to the underlying type of diabetes into three groups: type 1 diabetes, type 2 or secondary diabetes, and DKA as the first presentation of diabetes. Outcomes of interest were the rate of metabolic complications (hypoglycaemia or hypokalaemia) and the recovery time. Results Of 122 patients, 60 (49.2%) had type 1 diabetes, 28 (22.9%) had type 2 or secondary diabetes and 34 (27.9%) presented with DKA as the first presentation of diabetes (newly diagnosed diabetes). Despite having received lower insulin doses, hypoglycaemia was more frequent in patients with type 1 diabetes (76.9%) than in patients with type 2 or secondary diabetes (50.0%) and in patients with newly diagnosed diabetes (54.6%) (p = 0.026). In contrast, hypokalaemia was more frequent in the latter group (82.4%) than in patients with type 1 diabetes (57.6%) and type 2 or secondary diabetes (51.9%) (p = 0.022). The median recovery times were not significantly different between groups. Conclusions Rates of metabolic complications associated with DKA treatment differ significantly according to underlying type of diabetes. Decreasing insulin dose may limit those complications. DKA treatment recommendations should take into account the type of diabetes.http://link.springer.com/article/10.1186/s13613-019-0567-yDiabetic ketoacidosisHypoglycaemiaHypokalaemiaInsulinCritical careType 1 diabetes
spellingShingle Adrien Balmier
Fadia Dib
Arnaud Serret-Larmande
Etienne De Montmollin
Victorine Pouyet
Benjamin Sztrymf
Bruno Megarbane
Abirami Thiagarajah
Didier Dreyfuss
Jean-Damien Ricard
Damien Roux
Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study
Annals of Intensive Care
Diabetic ketoacidosis
Hypoglycaemia
Hypokalaemia
Insulin
Critical care
Type 1 diabetes
title Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study
title_full Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study
title_fullStr Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study
title_full_unstemmed Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study
title_short Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study
title_sort initial management of diabetic ketoacidosis and prognosis according to diabetes type a french multicentre observational retrospective study
topic Diabetic ketoacidosis
Hypoglycaemia
Hypokalaemia
Insulin
Critical care
Type 1 diabetes
url http://link.springer.com/article/10.1186/s13613-019-0567-y
work_keys_str_mv AT adrienbalmier initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT fadiadib initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT arnaudserretlarmande initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT etiennedemontmollin initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT victorinepouyet initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT benjaminsztrymf initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT brunomegarbane initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT abiramithiagarajah initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT didierdreyfuss initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT jeandamienricard initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy
AT damienroux initialmanagementofdiabeticketoacidosisandprognosisaccordingtodiabetestypeafrenchmulticentreobservationalretrospectivestudy